Franco Locatelli to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Franco Locatelli has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
1.214
-
Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia. Br J Haematol. 2019 04; 185(2):360-363.
Score: 0.349
-
The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood. Br J Haematol. 2017 02; 176(4):629-636.
Score: 0.315
-
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study. J Clin Oncol. 2019 09 01; 37(25):2246-2256.
Score: 0.093
-
Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL. Blood. 2018 07 26; 132(4):405-412.
Score: 0.086
-
Long-term results of the AIEOP MH'96 childhood Hodgkin's lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy. Leuk Lymphoma. 2018 11; 59(11):2612-2621.
Score: 0.085
-
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000). J Clin Oncol. 2018 01 20; 36(3):244-253.
Score: 0.083
-
Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL. Blood. 2017 11 09; 130(19):2146-2149.
Score: 0.082
-
The prognostic value of biological markers in paediatric Hodgkin lymphoma. Eur J Cancer. 2016 Jan; 52:33-40.
Score: 0.073
-
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. Br J Haematol. 2002 Sep; 118(3):741-7.
Score: 0.029
-
Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol. Br J Haematol. 2017 04; 177(1):116-126.
Score: 0.020